BSX Boston Scientific Corporation
$41.00▼ -9.02%
Healthcare
Other
Volume 15.00M
Avg Volume (10D) 14.07M
Key Metrics & Fundamentals
Market Cap
$59.41B
P/E Ratio
16.6
Div Yield
0.00%
52W Range
39.57 - 105.65
% vs 50 MA
-0.51%
% vs 200 MA
-21.36%
RSI-14
53.1
MACD Histogram
+0.3400
Beta (1Y vs SPY)
0.14
Free Cash Flow
-$451.00M
Gross Rev
$5.44B
Gross Profit
$3.85B
EBITDA
$1.58B
COGS
$1.59B
Operating Exp
$2.60B
Operating Income
$1.25B
EBIT
$1.25B
Pretax Income
$1.06B
Net Income
$907.00M
EPS (Diluted)
0.61
Price & Volume History
Loading chart…
Recent News

Boston Scientific Lowers Full-Year Outlook Amid Cyberattack Impact
MT Newswires · Oct 28, 2026 10:55 AM ET
BSX Stock Crashes To 4-Year Lows: Boston Scientific Sees Q4 Sales Declining, CEO Remains Confident In ‘Long-Term Strategy’
Stocktwits · Oct 28, 2026 10:36 AM ET

Boston Scientific Warned You. It Slashed Earnings Guidance After Cyberattack Hits Business.
Barrons.com · Oct 28, 2026 10:02 AM ET

Boston Scientific Shares Fall 3.5% as Earnings Miss and Lower Guidance Offset Revenue Growth
InvestorsHub · Oct 28, 2026 9:47 AM ET

Boston Scientific cuts annual forecast after quarterly profit falls
Proactive · Oct 28, 2026 9:34 AM ET

Boston Scientific Crashes 11% As Cybersecurity Attack Weighs On Guide
Investor's Business Daily · Oct 28, 2026 9:12 AM ET

Boston Scientific Falls on Sales Hit After August Cyberattack
Bloomberg · Oct 28, 2026 8:56 AM ET

Compared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key Metrics
Zacks · Oct 28, 2026 8:30 AM ET

Boston Scientific Cuts View Again After Cyberattack, Other Challenges
The Wall Street Journal · Oct 28, 2026 7:30 AM ET
Boston Scientific Q3 Adjusted Earnings Fall, Revenue Rises
MT Newswires · Oct 28, 2026 7:20 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See BSX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.